APC Conjugated KanryAb Anti-Human CD19 mAb

Localized Application Scenarios Scenario 1：Immunology CRO Local Pain Point：Many APC-conjugated CD19 antibodies suffer from high non-specific binding, which increases background and reduces accuracy of lymphocyte immunophenotyping. Our Advantage：Our Immunophenotyping Reagent Anti Human CD19 APC features optimized conjugation technology, reducing non-specific background signal by 34% and improving target population resolution. Scenario 2：University Flow Core Facility for Cell Sorting Local Pain Point：APC fluorophore is sensitive to light exposure and freeze-thaw cycles, leading to signal decay and unreliable cell sorting results. Our Advantage：Advanced fluorophore protection technology retains over 95% of APC fluorescence intensity after three freeze-thaw cycles, fully compatible with our Cell Sorting Product Series. Scenario3：Biotech R&D for Immunoassay Method Development Local Pain Point：Long lead times and inconsistent batch-to-batch variation delay assay validation timel…

Bioanalysis